- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat ; volume:15 ; number:1 ; day:27 ; month:5 ; year:2014 ; pages:1-8 ; date:12.2014
BMC pharmacology & toxicology ; 15, Heft 1 (27.5.2014), 1-8, 12.2014
- Urheber
-
Hole, Lisa Drange
- Beteiligte Personen und Organisationen
-
Larsen, Terje Hjalmar
Fossan, Kjell Ove
Limé, Fredrik
SchjøTt, Jan
SpringerLink (Online service)
- DOI
-
10.1186/2050-6511-15-28
- URN
-
urn:nbn:de:1111-2016071827849
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hole, Lisa Drange
- Larsen, Terje Hjalmar
- Fossan, Kjell Ove
- Limé, Fredrik
- SchjøTt, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice
Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
Glycine protects against doxorubicin-induced heart toxicity in mice
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis
Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
The significance of the apelinergic system in doxorubicin-induced cardiotoxicity
Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity